Shigellosis
Clinical trials for Shigellosis explained in plain language.
Never miss a new study
Get alerted when new Shigellosis trials appear
Sign up with your email to follow new studies for Shigellosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shigella vaccine shows promise for infants in phase 2 trial
Vaccine CompletedThis study tested a new vaccine called Shigella4V2 to protect infants against shigellosis, a severe diarrheal disease. Researchers gave the vaccine to 110 healthy 9-month-old babies to check its safety and how well it triggers an immune response. The goal is to find the best dose…
Matched conditions: SHIGELLOSIS
Phase 2 • Sponsor: LimmaTech Biologics AG • Aim: Vaccine
Last updated Aug 09, 2026 00:00 UTC
-
New vaccine aims to protect infants from deadly diarrhea
Vaccine CompletedThis study tests a new vaccine called Shigella4V, designed to protect against shigellosis, a severe diarrheal disease. Researchers are giving the vaccine to healthy adults, children, and 9-month-old infants to check its safety and whether it triggers a strong immune response. Dif…
Matched conditions: SHIGELLOSIS
Phase 1/2 • Sponsor: LimmaTech Biologics AG • Aim: Vaccine
Last updated Jun 27, 2026 14:03 UTC
-
Can a pill replace an IV for Drug-Resistant shigella in children?
Disease control CompletedThis trial tests whether an oral antibiotic called tebipenem-pivoxil works as well as the standard IV antibiotic ceftriaxone for children with shigellosis, a severe diarrheal disease, when first-line treatment fails. The study enrolls children aged 24 to 59 months who have not im…
Matched conditions: SHIGELLOSIS
Phase 2 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC